Results 111 to 120 of about 8,911,089 (208)

Time-Dependent Risk for Recurrence in Survivors of Major Adverse Cardiovascular Events

Cureus
The prevalence of the population with a history of an occlusive cardiovascular event has been increasing in recent years, which means that a large number of patients will have a higher risk of presenting a fatal recurrence. The aim is to determine variables associated with time-to-recurrent cardiovascular events and analyze how changes in low-density ...
Bermon, Anderson, Trejo-Valdivia, Belem, Molina Castaño, Carlos Federico, Segura, Angela M, Serrano, Norma C   +4 more
openaire   +2 more sources

Association of plasma angiogenin with risk of major cardiovascular events in type 2 diabetes

Cardiovascular Diabetology
Background Angiogenin, an enzyme belonging to the ribonucleases A superfamily, plays an important role in vascular biology. Here, we sought to study the association of plasma angiogenin and major adverse cardiovascular events (MACEs) in patients with ...
Resham L. Gurung, Sylvia Liu, Jian-Jun Liu, Yiamunaa M., Huili Zheng, Clara Chan, Keven Ang, Tavintharan Subramaniam, Chee Fang Sum, Su Chi Lim   +9 more
doaj   +1 more source

The prevalence of in-hospital all-cause mortality or major adverse cardiovascular events in patients with or without contrast-induced nephropathy.

, 2014
The prevalence of in-hospital all-cause mortality or major adverse cardiovascular events in patients with or without contrast-induced nephropathy.
Ping-Yan Chen (467931), Jian-fang Luo (652078), Ying-ling Zhou (626587), Yuan-hui Liu (652076), Wei-Guo (652080), Ji-yan Chen (626581), Yong Liu (6908), Ning Tan (547708), Li-wen Li (626583), Chong-yang Duan (652077), Hua-long Li (652079)   +10 more
core   +1 more source

Comparison of ezetimibe and atorvastatin versus atorvastatin alone on short-term major adverse cardiac events after percutaneous coronary intervention, a double-blind placebo-controlled randomized clinical trial

Trials
Background Major cardiovascular events (MACE) after percutaneous coronary intervention (PCI) are among the most common causes of death in patients. Lipid-lowering strategies seem to affect these events.
Hossein Farshidi, Badri Bijani, Seyed Alireza Sobhani, Farideh Dastsouz, Shahin Abbaszadeh   +4 more
doaj   +1 more source

No Increased Risk of Major Adverse Cardiovascular Events following Nicotinamide Exposure

ABSTRACT IMPORTANCE Nicotinamide metabolites have recently been implicated in increased risk of major cardiovascular events (MACE). Supportive data about clinical risk of MACE for nicotinamide users is lacking.
Lee Wheless, Ranya Guennoun, Basia Michalski-McNeely, Katlyn M Gonzalez, Rachel Weiss, Siwei Zhang, Lydia Yao, Chris Madden, Hua-Chang Chen, Jefferson L Triozzi, Ran Tao, Otis Wilson, Quinn S Wells, Adriana Hung, Kristin Bibee, Rebecca I Hartman, Yaomin Xu   +16 more
openaire   +2 more sources

Lipoprotein(a) as a Predictor of Major Adverse Cardiovascular Events in Patients with Acute Coronary Syndrome. [PDF]

J Clin Med
Li X, Zhang H, Bai J, Shi S, Sun C.
europepmc   +1 more source

Association of Moderate Coronary Artery Disease Burden With Major Adverse Cardiovascular Events Following Kidney Transplantation. [PDF]

Transplant Proc
Sriram A, Hobbs S, Peddada V, Okeke B, Parker AD, Lentine K, Benjamin MM, Lin CJ.   +7 more
europepmc   +1 more source

Construction and evaluation of risk prediction model for major adverse cardiovascular events in peritoneal dialysis patients. [PDF]

Front Nephrol
Han J, Guo X, Liu X, Sun J, Li F, Gao Y.
europepmc   +1 more source

Metabolic vulnerability index and Life's Essential 8 with risk of major adverse cardiovascular events. [PDF]

NPJ Cardiovasc Health
Wang X, Gao Y, Lip GYH, Guo J, Zhang J.
europepmc   +1 more source

Association of Mammographic Features and Major Adverse Cardiac Events in Postmenopausal Women: A 10-Year Retrospective Cohort Study [PDF]

Yunting Hu, Zheng Wang, Zengfa Huang, Yun Hu, Xiang Wang Department of Radiology, the Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430013, People’s Republic of ChinaCorrespondence: Xiang ...
Hu Y, Huang Z, Wang X, Wang Z
core